Patent · US Active

Recombinase-based amplification with substitute nucleotides

US9062336B1 · kind B1 · utility

1Cited by
0References
3Claims
0Family size

Inventors

Key dates

Filing dateMar 7, 2013
Grant dateJun 23, 2015
Priority date
Expiry dateJul 18, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6844
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This invention covers methods for isothermal amplification of DNA. It is based on the unexpected discovery that primers having, at some positions, adenine substituted by 2-aminopurine or diaminopurine, guanine by inosine, thymine by 2-thiothymine, and cytosine by N4-ethylcytosine (“substituted primers”) were accepted by enzymes used in the standard recombinase polymerase assay (RPA). Further unexpected was the discovery that target nucleotides are efficiently amplified in an RPA-like process (hereinafter abbreviated as simply RPA) using substituted primers. RPA-like processes were also discovered to amplify target DNA with substituted primers tagged with oligonucleotides incorporating nucleotides from an artificially expanded genetic information system (AEGIS).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.